Open Accessibility Menu

Clinical Trial Information

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
  • Category: Colon, Colorectal
  • Stage: II,III

Description of Trial:

The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA™ test results and may be recommended for adjuvant chemotherapy or observation by their treating clinician. Patients will be followed for up to two years with periodic whole blood collection. The study also has a control arm that will consist of matched Stage II or Stage III CRC cases that have a minimum of least 2 years clinical follow-up data. 

For all information regarding this clinical trial please visit: